Remedium Lifecare Limited (BOM:539561)

Market Cap	439.49M
Revenue (ttm)	4.05B
Net Income (ttm)	21.29M
Shares Out	403.20M
EPS (ttm)	0.05
PE Ratio	21.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	73,651,240
Average Volume	9,156,786
Open	1.090
Previous Close	1.140
Day's Range	1.090 - 1.180
52-Week Range	1.090 - 21.670
Beta	1.50
RSI	16.54
Earnings Date	May 27, 2025

About Remedium Lifecare

Remedium Lifecare Limited, a pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, io...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In 2024, Remedium Lifecare's revenue was 4.05 billion, a decrease of -89.97% compared to the previous year's 40.42 billion. Earnings were 21.29 million, a decrease of -93.49%.